Oncology Pharma
(OTC) ONPH
Oncology Pharma Financials at a Glance
Market Cap
$2.13M
Revenue (TTM)
$0.00
Net Income (TTM)
$5.60M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-1237.66 (Low)
Dividend
$0.00
Beta (Volatility)
-1237.66 (Low)
Price
$0.05
Volume
215,295
Open
$0.09
Price
$0.05
Volume
215,295
Open
$0.09
Previous Close
$0.05
Daily Range
$0.05 - $0.36
52-Week Range
$0.05 - $0.36
Dividend
$0.00
Beta (Volatility)
-1237.66 (Low)
Price
$0.05
Volume
215,295
Open
$0.09
Previous Close
$0.05
Daily Range
$0.05 - $0.36
52-Week Range
$0.05 - $0.36
ONPH News
ONPH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oncology Pharma
Industry
Biotechnology
Sector
Health CareCEO
George Malesek
Website
www.SourcingLink.netHeadquarters
San Francisco, CA 94104, US
ONPH Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-5%
Return on Assets
-49%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.13M
Shares Outstanding
27.39M
Volume
215.29K
Short Interest
0.00%
Avg. Volume
19.73K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$62.05K
EBITDA
$228.68K
Operating Cash Flow
$368.61K
Capital Expenditure
$0.00
Free Cash Flow
$368.61K
Cash & ST Invst.
$3.96K
Total Debt
$662.08K
Oncology Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.13M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$820.00
+99.0%
EBITDA
$820.00
+99.0%
Quarterly Fundamentals
Net Cash
$777.22K
-368.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$777.62K
+362.9%
Return on Assets
-49.29%
N/A
Return on Invested Capital
-4.98%
N/A
Free Cash Flow
$1.98K
-98.4%
Operating Cash Flow
$1.98K
-98.4%